Kidney Cancer
Showing 9976 - 10000 of >10,000
Screening Contrast-enhanced Mammography
Recruiting
- Breast Cancer
-
Quebec City, Quebec, CanadaSt-Sacrement Hospital
May 20, 2022
Malignant Tumors of Digestive Organs, Colorectal Cancer, Colon Cancer Trial in Houston (Durvalumab, Trametinib)
Completed
- Malignant Neoplasms of Digestive Organs
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
May 23, 2022
Cancer, Dignity Trial (Dignity therapy, standardize care)
Not yet recruiting
- Cancer
- Dignity
- Dignity therapy
- standardize care
- (no location specified)
Oct 23, 2023
Total Mesorectal Excision, Rectal Tumors, Robotic Surgical Procedures Trial in Changchun (Robotic-assisted total mesorectal
Not yet recruiting
- Total Mesorectal Excision
- +3 more
- Robotic-assisted total mesorectal excision
- laparoscopic-assisted total mesorectal excision
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
Oct 23, 2023
Lung Tumor, Pulmonary Metastasis Trial in Großhansdorf (Hyperspectral Imaging)
Not yet recruiting
- Lung Neoplasm
- Pulmonary Metastasis
- Hyperspectral Imaging
-
Großhansdorf, GermanyLungenClinic Großhansdorf
Jan 6, 2023
Cancer of Unknown Primary Site Trial in Worldwide (Alectinib, Vismodegib, Ipatasertib)
Active, not recruiting
- Cancer of Unknown Primary Site
- Alectinib
- +17 more
-
Blacktown, New South Wales, Australia
- +140 more
Jan 6, 2023
Locally Advanced Skin Squamous Cell Carcinoma, Resectable Skin Squamous Cell Carcinoma, Unresectable Skin Squamous Cell
Recruiting
- Locally Advanced Skin Squamous Cell Carcinoma
- +2 more
- Atezolizumab
- Stereotactic Body Radiation Therapy
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 2, 2022
Breast Cancer, Cancer Trial in Worldwide (Nivolumab, Anastrozole, Palbociclib)
Completed
- Breast Cancer
- Cancer
- Nivolumab
- +2 more
-
Whittier, California
- +35 more
Jul 14, 2022
Pancreas Cancer Trial in Scottsdale (Lurbinectedin 4 MG Injection [Zepzelca])
Recruiting
- Pancreas Cancer
- Lurbinectedin 4 MG Injection [Zepzelca]
-
Scottsdale, ArizonaHonorHealth Research Institute
Aug 8, 2022
Nephrolithiasis Trial in Switzerland (Placebo oral capsule, 12.5 mg hydrochlorothiazide, 25.0 mg hydrochlorothiazide)
Active, not recruiting
- Nephrolithiasis
- Placebo oral capsule
- +3 more
-
Aarau, Switzerland
- +11 more
Jan 17, 2022
Recurrent DLBCL, Refractory DLBCL Trial in Duarte (procedure, biological, radiation)
Not yet recruiting
- Recurrent Diffuse Large B-Cell Lymphoma
- Refractory Diffuse Large B-Cell Lymphoma
- Biospecimen Collection
- +6 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 24, 2023
Smoking Trial (Low-dose chest CT scan)
Not yet recruiting
- Smoking
- Low-dose chest CT scan
- (no location specified)
Aug 2, 2022
Head Neck Cancer, Head and Neck Tumors, Xerostomia Trial in Granada (Energy density photobiomodulation (7.5), Energy density
Active, not recruiting
- Head and Neck Cancer
- +2 more
- Energy density photobiomodulation (7.5)
- +2 more
-
Granada, SpainFaculty of Health Sciences
Oct 22, 2022
Breast Cancer, Ovarian Cancer Trial in Guangzhou (Doxorubicin Hydrochloride Liposome Injection)
Recruiting
- Breast Cancer
- Ovarian Cancer
- Doxorubicin Hydrochloride Liposome Injection
-
Guangzhou, Guangdong, ChinaSun Yat-Sun Memorial Hospital, Sun Yat-Sun University
Mar 8, 2022
Rectal Mucinous Adenocarcinoma, Rectal Signet Ring Cell Adenocarcinoma, Recurrent Rectal Carcinoma Trial in Houston (drug,
Terminated
- Rectal Mucinous Adenocarcinoma
- +8 more
- Capecitabine
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Nov 21, 2022
Unresectable Pancreatic Cancer Trial (creon 35.000 Ph.U (R), Best Standarard of Care)
Not yet recruiting
- Unresectable Pancreatic Cancer
- creon 35.000 Ph.U (R)
- Best Standarard of Care
- (no location specified)
Oct 19, 2023
Gastric Cancer Trial in Shanghai (NK510, Tislelizumab,atezolizumab or Trastuzumab)
Enrolling by invitation
- Gastric Cancer
- NK510
- Tislelizumab,atezolizumab or Trastuzumab
-
Shanghai, ChinaShanghai Tenth People's Hospital
Oct 22, 2023
Renal Transplant Rejection Trial in Los Angeles (Prograf, Tacrolimus)
Completed
- Renal Transplant Rejection
-
Los Angeles, CaliforniaUCLA Kidney Transplant Research
Mar 31, 2022
Chronic Kidney Disease Trial in Seattle (D6-25-hydroxyvitamin D3)
Completed
- Chronic Kidney Disease
- D6-25-hydroxyvitamin D3
-
Seattle, WashingtonUniversity of Washington
Aug 31, 2021
Stomach Tumors Trial in Shanghai (Fruquintinib, Sintilimab)
Active, not recruiting
- Stomach Neoplasms
-
Shanghai, ChinaRenji Hospital
Apr 3, 2023
Salivary Gland Tumors Trial in Beijing (RC48-ADC)
Recruiting
- Salivary Gland Tumors
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Oct 28, 2022
BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma Trial in
Recruiting
- BCLC Stage B Hepatocellular Carcinoma
- +9 more
- Durvalumab
- Tremelimumab
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 15, 2022
Cervical Carcinoma, Malignant Female Reproductive System Tumor, Vaginal Carcinoma Trial in Philadelphia (Perflubutane
Recruiting
- Cervical Carcinoma
- +3 more
- Perflubutane Microbubble
- Contrast-Enhanced Ultrasound
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jul 5, 2022
Pancreatic Cancer Trial in New York (Chemotherapy, Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA))
Not yet recruiting
- Pancreatic Cancer
- Chemotherapy
- Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA)
-
New York, New YorkTisch Hospital
Feb 9, 2023